A transaction is expected to value the filtration business between $3.5 billion and $4 billion, the people added.

"The sale of the Purification & Filtration business is part of phase three of our transformation plan and follows a thorough analysis of the value and strategic alignment of our businesses," said ...

The Journal reported in October that Solventum, the healthcare company spun off from 3M last year, had retained bankers to explore a sale of its purification and filtration unit.

Solventum is selling its purification and filtration business to Thermo Fisher for $4.1 billion, using most of the proceeds to reduce debt. The deal is part of Solventum’s transformation ...

(NYSE: TMO) ("Thermo Fisher"), the world leader in serving science, today announced that the company has entered into a definitive agreement with Solventum (NYSE: SOLV) to acquire Solventum’s ...

Trian, which as per LSEG data had a 4.9% stake in Solventum as of December 31, had said divestitures could accelerate the company's ability to reduce debt and help it allocate resources for ...

It’s been almost a year since Solventum spun off as a separate business from 3M. Now, Solventum is orchestrating a spinoff of its own. On Tuesday, Solventum announced that it has lined up a deal ...

3M health care spinoff Solventum is selling its purification business to Thermo Fisher Scientific for $4.1 billion in cash to pay down its billions in outstanding debt. Solventum CEO Bryan Hanson ...

Solventum faces significant challenges in its turnaround, including slow-growing core businesses, share loss, and margin pressures, but management has experience in driving operational ...